Government & Politics

Judge rejects suspended cannabis chair’s appeal

An Appeals Court judge on Tuesday rejected suspended Cannabis Control Chairwoman Shannon O'Brien's petition, once again clearing the way for Treasurer Deborah Goldberg to schedule the meeting that could lead to O'Brien's firing.

Fallon HQ proposed for $87M conversion into 200+ apartments

A letter of interest submitted by Synergy and included as part of the agenda packet for Tuesday’s City Council meeting says a plan to convert office space to housing of this magnitude has not been previously attempted in Massachusetts.

Pressure on state budget mounts as tax collection slump drags on

With tax revenues running $769 million behind projections after December, the Healey administration last month slashed the year-end revenue estimate by $1 billion.

Worcester multifamily building sells for $1.25M, more than double its 2015 sale price

A six-unit apartment building on the shore of Indian Lake in Worcester has sold for $1.25 million, five years after it was sold for $720,000.

Major swaths of state’s healthcare system considered high risk due to patient backlog

Major swaths of the state's health care system are now considered "high risk," with the crisis largely fueled by a major backlog of patients waiting to be discharged from hospitals, the Massachusetts Health and Hospital Association said Monday.

Mass. receives $8M following settlement with pharmaceutical companies

Massachusetts will receive $8 million to address the opioid crisis as part of a $350 million national settlement with Publicis Health.

Legal team of suspended cannabis chair says they were unaware of federal probe

An attorney for suspended Cannabis Control Commission Chair Shannon O'Brien said Thursday he is not aware of any federal investigation into his client and has not seen the subpoena that the Boston Globe reported Thursday had been sent to state officials in the fall by federal prosecutors seeking information on O'Brien.

In wake of Uxbridge $1.2M lawsuit settlement, Worcester reveals it stopped collecting cannabis impact fees in early 2023

Worcester joined a growing list of municipalities no longer collecting community impact fees from cannabis businesses in January 2023, after collecting nearly $5.2 million in those fees from fiscal 2019 to 2023.

U.S. head of German drug manufacturer sees further growth in Milford

Though the name of the client and the cancer treatment it produces is confidential, Rentschler Biopharma's Tom Roberts says this is just the first in a new wave of business in Milford for the 150-year-old company.